Drug Shortage Report for CEFTAZIDIME FOR INJECTION BP

Last updated on 2022-07-15 History
Report ID 162210
Drug Identification Number 02437856
Brand name CEFTAZIDIME FOR INJECTION BP
Common or Proper name CEFTAZIDIME FOR INJECTION BP
Company Name STERIMAX INC
Market Status MARKETED
Active Ingredient(s) CEFTAZIDIME
Strength(s) 2G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 VIALS
ATC code J01DD
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2022-06-20
Actual start date
Estimated end date 2022-07-29
Actual end date 2022-07-14
Shortage status Resolved
Updated date 2022-07-15
Company comments Fresenius Kabi is an alternate supplier of Ceftazidime for Injection. Fresenius Kabi is aware of our impending supply interruption and will have product available for SteriMax’s contracted customers.
Health Canada comments
Tier 3 Status No
Contact Address 2770 PORTLAND DRIVE
OAKVILLE, ONTARIO
CANADA L6H 6R4
Company contact information 1-800-881-3550

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2022-07-15 French Compare
v4 2022-07-15 English Compare
v3 2022-06-21 English Compare
v2 2022-06-09 French Compare
v1 2022-06-09 English Compare

Showing 1 to 5 of 5